Alice Dewdney

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Alice Dewdney, David Cunningham, Josep Tabernero et al. · Journal of Clinical Oncology · 2012 · 387 citations · Full text

TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial

Francesco Sclafani, David González, David Cunningham et al. · JNCI Journal of the National Cancer Institute · 2014 · 53 citations · Full text

Correlation of bevacizumab-induced hypertension and outcome in the BOXER study, a phase II study of capecitabine, oxaliplatin (CAPOX) plus bevacizumab as peri-operative treatment in 45 patients with poor-risk colorectal liver-only metastases unsuitable for upfront resection

Alice Dewdney, David Cunningham, Yolanda Barbáchano et al. · British Journal of Cancer · 2012 · 35 citations · Full text

Metastatic Squamous Cell Carcinoma of the Anus: Time for a Shift in the Treatment Paradigm?

Alice Dewdney, Sheela Rao · ISRN Oncology · 2012 · 22 citations · Full text

Tumor Biology, Surgical Oncology, Urology +15

Addressing the variation in adjuvant chemotherapy treatment for colorectal cancer: Can a regional intervention promote national change?

John Taylor, Daniel Swinson, Jenny F. Seligmann et al. · International Journal of Cancer · 2020 · 17 citations · Full text